Answer
Gazyvaro (obinutuzumab), in combination with mycophenolate mofetil, is indicated for adults with active Class III or IV lupus nephritis, with or without concomitant Class V.
Sources for this answer
- Gazyvaro 1,000 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 20Document updated
Sources checked